Terms: = Prostate cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
24 results:
1. A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital.
Oliveira MJ; Costa S; Magalhães A; Garrido L; Peleteiro B; Fougo JL; Castedo S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11145-11156. PubMed ID: 37347260
[TBL] [Abstract] [Full Text] [Related]
2. Tumor Androgen Receptor Protein Level Is Positively Associated with a Better Overall Survival in Melanoma Patients.
Singh N; Khatib J; Chiu CY; Lin J; Patel TS; Liu-Smith F
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833272
[TBL] [Abstract] [Full Text] [Related]
3. Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples.
Husain H; Pavlick DC; Fendler BJ; Madison RW; Decker B; Gjoerup O; Parachoniak CA; McLaughlin-Drubin M; Erlich RL; Schrock AB; Frampton GM; Das Thakur M; Oxnard GR; Tukachinsky H
JCO Precis Oncol; 2022 Oct; 6():e2200261. PubMed ID: 36265119
[TBL] [Abstract] [Full Text] [Related]
4. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
5. Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast cancer Throughout Disease Progression.
Bos MK; Smid M; Sleijfer S; Martens JWM
JCO Precis Oncol; 2022 Jan; 6():e2100190. PubMed ID: 35050709
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey.
Sun P; Li Y; Chao X; Li J; Luo R; Li M; He J
BMC Cancer; 2020 Oct; 20(1):994. PubMed ID: 33054725
[TBL] [Abstract] [Full Text] [Related]
7. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
8. Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1.
Ku S; Balasubramanian A; Kao CS; Eisenberg ML; Skinner EC
Urology; 2020 Jul; 141():e49-e50. PubMed ID: 32289361
[TBL] [Abstract] [Full Text] [Related]
9. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.
Brock P; Bustamante Alvarez J; Mortazavi A; Roychowdhury S; Phay J; Khawaja RA; Shah MH; Konda B
Fam Cancer; 2020 Apr; 19(2):189-192. PubMed ID: 32052251
[TBL] [Abstract] [Full Text] [Related]
10. TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant prostate cancer.
Chapman L; Ledet EM; Barata PC; Cotogno P; Manogue C; Moses M; Christensen BR; Steinwald P; Ranasinghe L; Layton JL; Lewis BE; Sartor O
Clin Genitourin Cancer; 2020 Apr; 18(2):148-154. PubMed ID: 31822380
[TBL] [Abstract] [Full Text] [Related]
11. Multiparametric Ultrasound for prostate cancer Detection and Localization: Correlation of B-mode, Shear Wave Elastography and Contrast Enhanced Ultrasound with Radical prostatectomy Specimens.
Mannaerts CK; Wildeboer RR; Remmers S; van Kollenburg RAA; Kajtazovic A; Hagemann J; Postema AW; van Sloun RJG; J Roobol M; Tilki D; Mischi M; Wijkstra H; Salomon G
J Urol; 2019 Dec; 202(6):1166-1173. PubMed ID: 31246546
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.
Weindorf SC; Taylor AS; Kumar-Sinha C; Robinson D; Wu YM; Cao X; Spratt DE; Kim MM; Lagstein A; Chinnaiyan AM; Mehra R
Med Oncol; 2019 Feb; 36(3):27. PubMed ID: 30712214
[TBL] [Abstract] [Full Text] [Related]
13. Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Sonpavde G; Agarwal N; Pond GR; Nagy RJ; Nussenzveig RH; Hahn AW; Sartor O; Gourdin TS; Nandagopal L; Ledet EM; Naik G; Armstrong AJ; Wang J; Bilen MA; Gupta S; Grivas P; Pal SK; Lanman RB; Talasaz A; Lilly MB
Cancer; 2019 May; 125(9):1459-1469. PubMed ID: 30620391
[TBL] [Abstract] [Full Text] [Related]
14. Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8
Mo RJ; Han ZD; Liang YK; Ye JH; Wu SL; Lin SX; Zhang YQ; Song SD; Jiang FN; Zhong WD; Wu CL
Int J Cancer; 2019 Jun; 144(12):3099-3110. PubMed ID: 30537104
[TBL] [Abstract] [Full Text] [Related]
15. Coexistence of neurofibromatosis type 1 with multiple malignant neoplasia.
Przybylik-Mazurek E; Palen J; Pasternak-Pietrzak K; Sowa-Staszczak A; Brzozowska-Czarnek A; Hubalewska-Dydejczyk A
Neuro Endocrinol Lett; 2018 Sep; 39(3):149-155. PubMed ID: 30431740
[TBL] [Abstract] [Full Text] [Related]
16. Next-generation panel sequencing identifies
Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
[TBL] [Abstract] [Full Text] [Related]
17. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract] [Full Text] [Related]
18. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract] [Full Text] [Related]
19. Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of nf1-deficient cancer xenograft in mice.
Hirokawa Y; Nheu T; Grimm K; Mautner V; Maeda S; Yoshida M; Komiyama K; Maruta H
Cancer Biol Ther; 2006 Mar; 5(3):305-9. PubMed ID: 16418572
[TBL] [Abstract] [Full Text] [Related]
20. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract] [Full Text] [Related]
[Next]
